Purchase Order N0025922P0165
Award Date
6/11/22
Potential Completion Date
6/10/27
Potential Value
$130K
Federal Agency
Defense Health Agency
Awardee
Fenwal, Inc.
Ultimate Awardee
Not listed
PSC Category
J065 - Maint/Repair/Rebuild Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, for preventive maintenance of two AMICUS B-1 blood cell separators located at the Naval Medical Center San Diego. The contract, valued at $58,527.80, covers all parts, support, and labor charges for the maintenance of this specialized medical equipment. The contract does not have a set-aside designation, reflecting...
This is a federal purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi, for the supply of various blood collection and transfusion-related products and services. The contract, valued at $4,594.60, has an ultimate completion date of October 22, 2024. Fenwal, a global blood technology company, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to...
This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $31,342.00 contract is for preventative maintenance services on AMICUS apheresis separators. The contract has no set-aside designation and has an ultimate completion date of December 13, 2025. Fenwal is a registered vendor with the U.S. federal government and has a history of providing a range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
This federal contract award, valued at $1,062.50, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. The contract is for the supply of various blood collection and processing products, including blood bags, tubing, solutions, and apheresis equipment, to support transfusion medicine and cell therapy applications for federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health....
This federal contract award is to Fenwal, Inc., a global blood technology company, for the provision of a variety of blood collection, processing, and transfusion-related products and services. The contract, valued at $22,800.00, was awarded by the Office of the Chief Operating Officer and does not have a set-aside designation. Fenwal, a subsidiary of Fresenius Kabi, is a registered federal vendor that has supplied items such as blood bags, tubing, solutions, apheresis equipment, and...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Fenwal, Inc., a global blood technology company, for the AMICUS SOFTWARE DXT DATA MANAGER APPLICATION. The contract has a ceiling value of $29,200 and an ultimate completion date of September 15, 2025. Fenwal, a subsidiary of Fresenius Kabi, has been a registered vendor with the U.S. federal government since 2007 and has established itself as a key supplier to various agencies,...
This federal contract award, valued at $2,202.56, was issued by the Defense Logistics Agency's Medical Supply Chain division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the procurement of blood packs with anticoagulant, classified under the product code 8511121932. This is a firm fixed-price purchase order with a period of performance ending on March 17, 2025. The award does not have a set-aside designation, reflecting Fenwal's...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a purchase order contract to Fenwal, Inc., a global blood technology company, for a service agreement for a blood separator device. The firm-fixed-price contract, valued at $139,326.00, has a period of performance through June 30, 2025. Fenwal, a subsidiary of Fresenius Kabi, has received numerous federal contracts to provide blood collection, separation, storage, and transfusion products and...